Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Philip Nickson

Chief Business & Legal Officer at Monte Rosa Therapeutics, Inc. (GLUE)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $151K

Reported trades

Filed Stock Type Shares Price Value Since
Apr 10SEC GLUEMonte Rosa Therapeutics, Inc. Sell 5,84555,000 held (−10%) $17.69 $103K -44.9%
Jan 5SEC GLUEMonte Rosa Therapeutics, Inc. Sell 3,15560,845 held (−5%) $15.17 $48K -35.8%